US EditionSangamo Therapeutics Announces Second Quarter 2025 Earnings Call - Sangamo Therapeutics (NASDAQ:SGMO)
2 Articles
2 Articles
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its second quarter 2025 financial results after the markets close on Thursday, August 7, 2025.
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call - Sangamo Therapeutics (NASDAQ:SGMO)
RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company today announced that the company has scheduled the release of its second quarter 2025 financial results after the markets close on Thursday, August 7, 2025. The company will hold a conference call at 4:30 p.m. Eastern on Thursday, August 7, which will remain open to the public. During the conference call, the company will revi…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
